OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,350,000 | -42.2% | 6,000,000 | -29.1% | 0.00% | -50.0% |
| Q3 2016 | $2,337,000 | +0.5% | 8,459,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $2,326,000 | -32.8% | 8,459,000 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $3,463,000 | -31.0% | 8,459,000 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $5,021,000 | +3.3% | 8,459,000 | +20.8% | 0.01% | 0.0% |
| Q3 2015 | $4,862,000 | -10.4% | 7,000,000 | +48.4% | 0.01% | 0.0% |
| Q1 2015 | $5,424,000 | +14.3% | 4,717,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $4,745,000 | – | 4,717,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $3,550,000 | 0.43% |
| Telemetry Investments, L.L.C. | 2,500,000 | $875,000 | 0.33% |
| UBS OCONNOR LLC | 7,500,000 | $2,780,000,000 | 0.05% |